IOL Chemicals and Pharmaceuticals Limited, a trailblazer in the production of pharmaceuticals and specialty chemicals, has chosen Vikas Vij as its new Chief Executive Officer. This appointment, which takes effect on April 3, 2023, is poised to skyrocket the company’s growth in both domestic and international markets. With over three decades of experience in the pharma sector, including leadership positions at Cipla, Ranbaxy, GVK Biosciences, Alembic Pharmaceuticals, Sun Pharma, and Apollo Hospitals, Vij brings a wealth of expertise and a sharp understanding of the industry to the table.
Joint Managing Director of IOL Chemicals and Pharmaceuticals, Vikas Gupta, said, “We’re thrilled to welcome Vikas Vij as CEO of IOL Chemicals and Pharmaceuticals. He’s a seasoned leader with a proven track record of turbocharging sales and scaling businesses in the pharmaceutical and specialty chemicals domains. With his wealth of experience, we’re confident that he will lead IOL to new heights, both in India and beyond.”
Vij, who takes the reins from Dr. Sanjay Chaturvedi, added, “I’m eager to join forces with the dynamic team at IOL to drive its next phase of growth. It’s an honor to lead a company that is making such a meaningful impact on people’s lives and on the growth of the Indian Pharmaceutical Industry.”
IOL Chemicals and Pharmaceuticals is listed on the National Stock Exchange of India and the BSE and is a leading player in the specialty chemicals space. The company’s product portfolio includes APIs such as Ibuprofen and specialty chemicals like Ethyl Acetate, and it has a wide presence across major therapeutic categories. With a state-of-the-art facility and a commitment to sustainability, IOL Chemicals and Pharmaceuticals has an approved Effluent Treatment Plant with a Zero Liquid Discharge system and a 17 MW captive Co-Generation plant.